Src
Src (proto-oncogene tyrosine-protein kinase) is a non-receptor protein tyrosine kinase family including 9 members and promotes survival, angiogenesis, proliferation and invasion pathways.
- A3017 Dasatinib (BMS-354825)4 CitationSummary: Src and BCR-Abl inhibitor
- A3351 Dasatinib hydrochlorideSummary: Multi-BCR/Abl and Src kinase inhibitor, oral active
- A3535 KX2-391 dihydrochlorideTarget: SrcSummary: Src kinase inhibitor
- A3939 XL228Summary: IGF1R/AURORA /FGFR1-3/ABL/SRC family kinases inhibitor
- A8215 PP 1Target: Src|EGFR|JAK|ZAP-70Summary: Src family tyrosine kinase inhibitor
- A8216 PP 2 (AG 1879)1 CitationSummary: Src-family kinases inhibitor
- A2149 Bosutinib (SKI-606)1 CitationTarget: Bcr-Abl|SrcSummary: Potent Abl/Src kinases
- A2133 Saracatinib (AZD0530)3 CitationTarget: SrcSummary: Src/Abl inhibitor,potent and selective
- A8548 Fingolimod (FTY720)Target: S1P receptorsSummary: S1P receptors agonist
- A8683 NVP-BHG712Target: Eph Receptors|VEGFRSummary: EphB4 inhibitor,potent and selective